| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.7M | +46.3% |
| Cost of Revenue | $18.0M | +855.3% |
| Gross Profit | -$15.4M | — |
| R&D Expense | $45.3M | +86.6% |
| SG&A Expense | $37.1M | +267.8% |
| Operating Income | -$112.8M | -194.5% |
| Interest Expense | $79K | -0.1% |
| Pre-tax Income | -$105.0M | -168.0% |
| Income Tax | -$3.7M | — |
| Net Income | -$101.4M | -158.6% |
| EPS (Basic) | -$1.63 | -52.3% |
| EPS (Diluted) | -$1.63 | -52.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.2M | -13.8% |
| Accounts Receivable | $851K | +880.4% |
| Inventory | $0 | -100.0% |
| Current Assets | $241.1M | +92.5% |
| Total Assets | $367.8M | +163.4% |
| Current Liabilities | $13.3M | +95.4% |
| Total Liabilities | $17.0M | +114.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$80.2M | -272.5% |
| Capital Expenditures | $37.3M | +264.1% |
| Investing Cash Flow | -$198.0M | -1819.0% |
| Financing Cash Flow | $261.2M | +68.4% |
| Free Cash Flow | -$117.6M | -269.8% |
| $350.7M |
| +166.4% |